Ilana Richman, MD, MHS

• Baylah Tessier-Sherman
• Carol Oladele
• Cary Gross
• Howard Forman
• Jenerius Aminawung
• Joseph Ross
• Kunal Potnis
• Lisa Puglisi
• Sanjay Aneja
• Shi-Yi Wang
• Susan Busch
• Xiao Xu

Decision Making; Health Policy; Preventive Health Services

• Cancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort studyAminawung J, Soulos P, Oladeru O, Lin H, Gonsalves L, Puglisi L, Hassan S, Richman I, Wang E, Gross C. Cancer incidence among incarcerated and formerly incarcerated individuals: A statewide retrospective cohort study. Cancer Medicine 2023, 12: 15447-15454. PMID: 37248772, PMCID: PMC10417084, DOI: 10.1002/cam4.6162.
• ACR Appropriateness Criteria® Routine Chest ImagingImaging P, Bang T, Chung J, Walker C, Brixey A, Christensen J, Faiz S, Hanak M, Hobbs S, Kandathil A, Little B, Madan R, Moore W, Richman I, Setters B, Todd M, Yang S, Donnelly E. ACR Appropriateness Criteria® Routine Chest Imaging. Journal Of The American College Of Radiology 2023, 20: s224-s233. PMID: 37236745, DOI: 10.1016/j.jacr.2023.02.006.
• Eliminating Financial Barriers to Breast Cancer Screening—When Free Is Not Really FreeRichman I, Fendrick A. Eliminating Financial Barriers to Breast Cancer Screening—When Free Is Not Really Free. JAMA Network Open 2023, 6: e234898. PMID: 36972055, DOI: 10.1001/jamanetworkopen.2023.4898.
• Artificial Intelligence in Breast Cancer ScreeningPotnis K, Ross J, Aneja S, Gross C, Richman I. Artificial Intelligence in Breast Cancer Screening. JAMA Internal Medicine 2022, 182: 1306-1312. PMID: 36342705, DOI: 10.1001/jamainternmed.2022.4969.
• The role of lung cancer risk and comorbidity in lung cancer screening useRichman IB, Long JB, Poghosyan H, Sather P, Gross CP. The role of lung cancer risk and comorbidity in lung cancer screening use. Preventive Medicine Reports 2022, 30: 102006. PMID: 36203942, PMCID: PMC9530957, DOI: 10.1016/j.pmedr.2022.102006.
• Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equityRichman I, Tessier-Sherman B, Galusha D, Oladele CR, Wang K. Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity. Journal Of The National Cancer Institute 2022, 115: 139-145. PMID: 36069622, PMCID: PMC9494402, DOI: 10.1093/jnci/djac172.
• EP01.03-007 Lung Cancer Screening Use Among Screening-Eligible Adults With Disability in the United States: Evidence From Population-Based DataPoghosyan H, Richman I, Pannu J, Presley C. EP01.03-007 Lung Cancer Screening Use Among Screening-Eligible Adults With Disability in the United States: Evidence From Population-Based Data. Journal Of Thoracic Oncology 2022, 17: s174-s175. DOI: 10.1016/j.jtho.2022.07.289.
• Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screeningRichman IB, Prasad TV, Gross CP. Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening. Preventive Medicine Reports 2022, 29: 101909. PMID: 35911579, PMCID: PMC9326340, DOI: 10.1016/j.pmedr.2022.101909.
• Insurance Coverage Mandates and the Adoption of Digital Breast TomosynthesisRichman IB, Long JB, Kyanko KA, Xu X, Gross CP, Busch SH. Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis. JAMA Network Open 2022, 5: e224208. PMID: 35333358, PMCID: PMC8956980, DOI: 10.1001/jamanetworkopen.2022.4208.
• Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 YearsRichman IB, Long JB, Kunst N, Kyanko K, Xu X, Busch S, Gross CP. Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years. JAMA Internal Medicine 2021, 181: 1665-1668. PMID: 34459853, PMCID: PMC8406208, DOI: 10.1001/jamainternmed.2021.4832.
• Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older WomenUpneja A, Long JB, Aminawung JA, Kyanko KA, Kunst N, Xu X, Busch SH, Gross CP, Richman IB. Comparative Effectiveness of Digital Breast Tomosynthesis and Mammography in Older Women. Journal Of General Internal Medicine 2021, 37: 1870-1876. PMID: 34595682, PMCID: PMC8483166, DOI: 10.1007/s11606-021-07132-6.
• Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old.Richman IB, Long JB, Hoag JR, Upneja A, Hooley R, Xu X, Kunst N, Aminawung JA, Kyanko KA, Busch SH, Gross CP. Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old. Journal Of The National Cancer Institute 2021, 113: 1515-1522. PMID: 33822120, PMCID: PMC8757313, DOI: 10.1093/jnci/djab063.
• Understanding Regional Variation in the Cost of Breast Cancer Screening Among Privately Insured Women in the United StatesKunst N, Long JB, Xu X, Busch SH, Kyanko KA, Lindau ST, Richman IB, Gross CP. Understanding Regional Variation in the Cost of Breast Cancer Screening Among Privately Insured Women in the United States. Medical Care 2021, 59: 437-443. PMID: 33560712, PMCID: PMC8611614, DOI: 10.1097/mlr.0000000000001506.
• Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislationAminawung JA, Hoag JR, Kyanko KA, Xu X, Richman IB, Busch SH, Gross CP. Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation. Cancer Medicine 2020, 9: 5662-5671. PMID: 32537899, PMCID: PMC7402830, DOI: 10.1002/cam4.3218.
• Industry Payments and New Breast Cancer Screening Technology UsePotnis KC, Gross CP, Richman IB. Industry Payments and New Breast Cancer Screening Technology Use. Journal Of General Internal Medicine 2020, 36: 1440-1442. PMID: 32468434, DOI: 10.1007/s11606-020-05771-9.
• Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private InsuranceKunst N, Long JB, Xu X, Busch SH, Kyanko KA, Richman IB, Gross CP. Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine 2020, 180: 799-801. PMID: 32202606, PMCID: PMC7147248, DOI: 10.1001/jamainternmed.2020.0262.
• Dense Breast Notification Laws, Education, and Women’s Awareness and Knowledge of Breast Density: a Nationally Representative SurveyKyanko KA, Hoag J, Busch SH, Aminawung JA, Xu X, Richman IB, Gross CP. Dense Breast Notification Laws, Education, and Women’s Awareness and Knowledge of Breast Density: a Nationally Representative Survey. Journal Of General Internal Medicine 2020, 35: 1940-1945. PMID: 31916210, PMCID: PMC7351910, DOI: 10.1007/s11606-019-05590-7.
• Utilization and costs of breast cancer screening for women in their 40s in a privately insured U.S. population.Kunst N, Long J, Xu X, Busch S, Richman I, Kyanko K, Gross C. Utilization and costs of breast cancer screening for women in their 40s in a privately insured U.S. population. Journal Of Clinical Oncology 2019, 37: 105-105. DOI: 10.1200/jco.2019.37.27_suppl.105.
• Adoption of Digital Breast Tomosynthesis in Clinical PracticeRichman IB, Hoag JR, Xu X, Forman HP, Hooley R, Busch SH, Gross CP. Adoption of Digital Breast Tomosynthesis in Clinical Practice. JAMA Internal Medicine 2019, 179: 1292-1295. PMID: 31233086, PMCID: PMC6593646, DOI: 10.1001/jamainternmed.2019.1058.
• Advising Women About Supplemental Screening After Dense Breast NotificationRichman IB, Busch SH. Advising Women About Supplemental Screening After Dense Breast Notification. JAMA Internal Medicine 2019, 179: 1240-1241. PMID: 31260063, DOI: 10.1001/jamainternmed.2019.1737.
• Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography.Busch SH, Hoag JR, Aminawung JA, Xu X, Richman IB, Soulos PR, Kyanko KA, Gross CP. Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography. American Journal Of Public Health 2019, 109: 762-767. PMID: 30896987, PMCID: PMC6459654, DOI: 10.2105/ajph.2019.304967.
• New Breast Cancer Screening Technologies in Older Women—Is It Time to Pump the Brakes?Richman IB, Gross CP. New Breast Cancer Screening Technologies in Older Women—Is It Time to Pump the Brakes? JAMA Internal Medicine 2019, 179: 289-290. PMID: 30640376, DOI: 10.1001/jamainternmed.2018.7767.
• Weighing the Harms and Benefits of Using Statins for Primary Prevention: Raising the Risk Threshold.Richman IB, Ross JS. Weighing the Harms and Benefits of Using Statins for Primary Prevention: Raising the Risk Threshold. Annals Of Internal Medicine 2018, 170: 62-63. PMID: 30508426, DOI: 10.7326/m18-3066.
• State breast density inform mandate laws and utilization of adjunctive screening tests and cancer detection following screening mammography.Gross C, Hoag J, Xu X, Richman I, Aminawung J, Soulos P, Busch S. State breast density inform mandate laws and utilization of adjunctive screening tests and cancer detection following screening mammography. Journal Of Clinical Oncology 2018, 36: 6579-6579. DOI: 10.1200/jco.2018.36.15_suppl.6579.
• Early adoption of digital breast tomosynthesis in the United States.Richman I, Hoag J, Busch S, Gross C. Early adoption of digital breast tomosynthesis in the United States. Journal Of Clinical Oncology 2018, 36: e13543-e13543. DOI: 10.1200/jco.2018.36.15_suppl.e13543.
• Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal.Wang SY, Dang W, Richman I, Mougalian SS, Evans SB, Gross CP. Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal. Journal Of Clinical Oncology 2018, 36: 1619-1627. PMID: 29659329, PMCID: PMC5978470, DOI: 10.1200/jco.2017.76.5941.
• Lessons From the Opioid Epidemic to Reinvigorate Tobacco Control InitiativesRichman I, Krumholz H. Lessons From the Opioid Epidemic to Reinvigorate Tobacco Control Initiatives. JAMA 2018, 319: 339-340. PMID: 29309495, DOI: 10.1001/jama.2017.19739.
• Aspirin for Primary PreventionRichman IB, Owens DK. Aspirin for Primary Prevention. Medical Clinics Of North America 2017, 101: 713-724. PMID: 28577622, DOI: 10.1016/j.mcna.2017.03.004.
• Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER RegistryRichman I, Asch SM, Bendavid E, Bhattacharya J, Owens DK. Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER Registry. Journal Of General Internal Medicine 2016, 32: 603-609. PMID: 27844260, PMCID: PMC5442000, DOI: 10.1007/s11606-016-3904-y.
• Cost-effectiveness of Intensive Blood Pressure ManagementRichman IB, Fairley M, Jørgensen ME, Schuler A, Owens DK, Goldhaber-Fiebert JD. Cost-effectiveness of Intensive Blood Pressure Management. JAMA Cardiology 2016, 1: 872-879. PMID: 27627731, PMCID: PMC5892423, DOI: 10.1001/jamacardio.2016.3517.
• Colorectal Cancer Screening in the Era of the Affordable Care ActRichman I, Asch SM, Bhattacharya J, Owens DK. Colorectal Cancer Screening in the Era of the Affordable Care Act. Journal Of General Internal Medicine 2015, 31: 315-320. PMID: 26349953, PMCID: PMC4762811, DOI: 10.1007/s11606-015-3504-2.
• European genetic ancestry is associated with a decreased risk of lupus nephritisRichman IB, Taylor KE, Chung SA, Trupin L, Petri M, Yelin E, Graham RR, Lee A, Behrens TW, Gregersen PK, Seldin MF, Criswell LA. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis & Rheumatism 2012, 64: 3374-3382. PMID: 23023776, PMCID: PMC3865923, DOI: 10.1002/art.34567.
• National Study of the Relation of Primary Care Shortages to Emergency Department UtilizationRichman I, Clark S, Sullivan A, Camargo C. National Study of the Relation of Primary Care Shortages to Emergency Department Utilization. Academic Emergency Medicine 2007, 14: 279-282. DOI: 10.1111/j.1553-2712.2007.tb01788.x.
• National Study of the Relation of Primary Care Shortages to Emergency Department UtilizationRichman IB, Clark S, Sullivan AF, Camargo CA. National Study of the Relation of Primary Care Shortages to Emergency Department Utilization. Academic Emergency Medicine 2007, 14: 279-282. PMID: 17242383, DOI: 10.1197/j.aem.2006.10.093.